These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7636387

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J, Wang MG, Pearson DA, Szot GL, Sykes M.
    Transplantation; 1994 Dec 27; 58(12):1385-93. PubMed ID: 7809932
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M, Yabe H, Hattori K, Hinohara T, Morimoto T, Kato S, Kusunoki A.
    Bone Marrow Transplant; 1994 Nov 27; 14(5):741-6. PubMed ID: 7889006
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y, Yoshihara S, Hoshida Y, Inoue T, Fujioka T, Ikegame K, Kawakami M, Masuda T, Aozasa K, Kawase I, Ogawa H.
    Exp Hematol; 2008 Sep 27; 36(9):1216-25. PubMed ID: 18599183
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients.
    Yabe M, Yabe H, Hattori K, Shimizu T, Matsumoto M, Morimoto T, Yasuda Y, Inoue H, Kato S, Nishimura T.
    Bone Marrow Transplant; 1999 Jul 27; 24(1):29-34. PubMed ID: 10435731
    [Abstract] [Full Text] [Related]

  • 12. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
    Takabayashi M, Kanamori H, Takasaki H, Yamaji S, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujisawa S, Maruta A, Ishigatsubo Y.
    Exp Hematol; 2005 Feb 27; 33(2):251-7. PubMed ID: 15676220
    [Abstract] [Full Text] [Related]

  • 13. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.
    Transpl Immunol; 2006 Jan 27; 15(3):223-7. PubMed ID: 16431290
    [Abstract] [Full Text] [Related]

  • 14. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 15. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V, Castagnola E, Dallorso S, Lanino E, Calvi A, Silvestro S, Morreale G, Giacchino R, Dini G.
    Bone Marrow Transplant; 1999 Feb 01; 23(3):271-5. PubMed ID: 10084259
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC.
    Bone Marrow Transplant; 1996 Jan 01; 17(1):13-8. PubMed ID: 8673048
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, Todisco E, Rahal D, Migliavacca M, Longoni D, Solinas G, Villa A, Berti E, Mina PD, Parma M, Allavena P, Biagi E, Rovelli A, Biondi A, D'Amico G.
    Transplantation; 2009 Dec 15; 88(11):1261-72. PubMed ID: 19996925
    [Abstract] [Full Text] [Related]

  • 19. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Körholz D, Kunst D, Hempel L, Söhngen D, Heyll A, Bönig H, Göbel U, Zintl F, Burdach S.
    Bone Marrow Transplant; 1997 Apr 15; 19(7):691-5. PubMed ID: 9156246
    [Abstract] [Full Text] [Related]

  • 20. Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation.
    Abedi MR, Bäckman L, Boström L, Lindbäck B, Ringdén O.
    Bone Marrow Transplant; 1990 Aug 15; 6(2):121-6. PubMed ID: 2207449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.